Purchases and Sales Made in Q2 2024 in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA) during Q2 2024. The information is specifically focused on institutions that hold shares of Akebia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 31, 2024
Q2 2024
|
Laurel Wealth Advisors LLC
Charlotte, NC |
BUY
|
- |
229New |
$197 - $373
|
229
$845
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 29, 2025
Q2 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-514- 2.78% |
$442 - $838
|
18K
$66.3K
|
|
|
Jul 31, 2024
Q2 2024
|
Commonwealth Equity Services, LLC
|
SELL
|
- |
-1.28K- 5.83% |
$1.1K - $2.09K
|
20.7K
$76.5K
|
|
|
Aug 08, 2024
Q2 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-1.3K- 0.15% |
$1.12K - $2.12K
|
865K
$3.19M
|
|
|
Aug 07, 2024
Q2 2024
|
Headlands Technologies LLC
Chicago, IL |
SELL
|
- |
-2.53K- 92.4% |
$2.17K - $4.12K
|
208
$768
|
|
|
Aug 14, 2024
Q2 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-8.1K- 5.06% |
$6.97K - $13.2K
|
152K
$560K
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-9.66K- 9.8% |
$8.31K - $15.7K
|
88.9K
$328K
|
|
|
Aug 13, 2024
Q2 2024
|
Orchard Capital Managment, LLC
Chicago, IL |
SELL
|
- |
-21.6K- 19.95% |
$18.6K - $35.3K
|
86.8K
$320K
|
|
|
Aug 13, 2024
Q2 2024
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-23.8K- 62.56% |
$20.5K - $38.9K
|
14.3K
$52.7K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-25K- 3.18% |
$21.5K - $40.8K
|
763K
$2.82M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-25K- 3.18% |
$21.5K - $40.8K
|
763K
$2.82M
|
|
|
Aug 13, 2024
Q2 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-32K- 92.22% |
$27.5K - $52.1K
|
2.69K
$9.94K
|
|
|
Aug 14, 2024
Q2 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-48.9K- 27.35% |
$42.1K - $79.7K
|
130K
$479K
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-128K- 36.1% |
$110K - $209K
|
227K
$838K
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-137K- 65.43% |
$118K - $224K
|
72.6K
$268K
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-141K- 75.21% |
$121K - $230K
|
46.6K
$172K
|
|
|
Aug 12, 2024
Q2 2024
|
Marathon Trading Investment Management LLC
Radnor, PA |
SELL
|
- |
-207K- 79.75% |
$178K - $338K
|
52.7K
$194K
|
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-216K- 84.86% |
$186K - $352K
|
38.6K
$142K
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-272K- 68.22% |
$234K - $443K
|
126K
$467K
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-518K- 22.9% |
$446K - $844K
|
1.74M
$6.44M
|
|
|
Jul 18, 2024
Q2 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-579K- 73.23% |
$498K - $944K
|
212K
$781K
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-776K- 75.86% |
$668K - $1.27M
|
247K
$912K
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.03M- 57.36% |
$883K - $1.67M
|
763K
$2.82M
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.06M- 75.32% |
$916K - $1.74M
|
349K
$1.29M
|
|
|
Aug 06, 2024
Q2 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-1.25M- 23.47% |
$1.07M - $2.03M
|
4.06M
$15M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-1.51M- 85.88% |
$1.3M - $2.47M
|
249K
$918K
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-3.22M- 98.6% |
$2.77M - $5.25M
|
45.7K
$169K
|
|
|
Aug 14, 2024
Q2 2024
|
Satter Management Co., L.P.
|
SELL
|
- |
-7.46M- 56.47% |
$6.41M - $12.2M
|
5.75M
$21.2M
|